Biological evaluation of 2,3-dioxoindolin-N-phenylacetamide derivatives as potent CDC25B and PTP1B phosphatase inhibitors. (2020). Brazilian Journal of Pharmaceutical Sciences, 56, e00222. https://doi.org/10.1590/s2175-97902019000400222